Related Experiment Video
Updated: Dec 25, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
A risk factor-based predictive model for new-onset hypertension during pregnancy in Chinese Han women
Yamin Hou1,2, Lin Yun3, Lihua Zhang3
1Department of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, 250014, P.R. China.
Insights
This study developed a prediction model for new-onset hypertension during pregnancy. The model effectively identifies high-risk pregnancies, enabling early intervention for better maternal and neonatal outcomes.
Area of Science:
- Obstetrics and Gynecology
- Cardiovascular Disease in Pregnancy
- Biomarker Research
Background:
- Hypertensive disorders of pregnancy (HDP) are a major cause of maternal and neonatal mortality.
- HDP increases the long-term risk of cardiovascular diseases.
- Preeclampsia and gestational hypertension are key components of HDP.
Purpose of the Study:
- To establish a prediction model for pregnant women with new-onset hypertension (de novo hypertension) after 20 weeks of gestation.
- To guide clinical prediction and treatment strategies for de novo hypertension.
- To enable early intervention for high-risk pregnancies.
Main Methods:
- A case-control study involving 117 pregnant women with de novo hypertension and 199 healthy controls.
- Collection of maternal clinical parameters and biomarkers (homocysteine, cystatin C, uric acid, etc.) between 16-20 weeks gestation.
- Logistic regression analysis to establish a prediction model.
Main Results:
- Eleven indicators showed statistically significant differences between groups (P < 0.05).
- A logistic regression model identified 7 independent predictors for de novo hypertension.
- The model achieved an area under the curve of 0.884, with 88.0% sensitivity and 75.0% specificity.
- A scoring system was developed to classify pregnancies into low-risk (≤15.5) and high-risk (>15.5) groups.
Conclusions:
- The developed regression equation offers a feasible and reliable method for predicting de novo hypertension in pregnancy.
- Risk stratification allows for targeted early treatment interventions in high-risk populations.
- This approach can improve maternal and neonatal outcomes by facilitating timely management of hypertension during pregnancy.
Background:
Hypertensive disorders of pregnancy (HDP) is one of the leading causes of maternal and neonatal mortality, increasing the long-term incidence of cardiovascular diseases. Preeclampsia and gestational hypertension are the major components of HDP. The aim of our study is to establish a prediction model for pregnant women with new-onset hypertension during pregnancy (increased blood pressure after gestational age > 20 weeks), thus to guide the clinical prediction and treatment of de novo hypertension.
Methods:
A total of 117 pregnant women with de novo hypertension who were admitted to our hospital's obstetrics department were selected as the case group and 199 healthy pregnant women were selected as the control group from January 2017 to June 2018. Maternal clinical parameters such as age, family history and the biomarkers such as homocysteine, cystatin C, uric acid, total bile acid and glomerular filtration rate were collected at a mean gestational age in 16 to 20 weeks. The prediction model was established by logistic regression.
Results:
Eleven indicators have statistically significant difference between two groups (P < 0.05). These 11 factors were substituted into the logistic regression equation and 7 independent predictors were obtained. The equation expressed including 7 factors. The calculated area under the curve was 0.884(95% confidence interval: 0.848-0.921), the sensitivity and specificity were 88.0 and 75.0%. A scoring system was established to classify pregnant women with scores ≤15.5 as low-risk pregnancy group and those with scores > 15.5 as high-risk pregnancy group.
Conclusions:
Our regression equation provides a feasible and reliable means of predicting de novo hypertension after pregnancy. Risk stratification of new-onset hypertension was performed to early treatment interventions in high-risk populations.
Related Concept Videos
Hypertension I: Introduction
Hypertension V: Nursing Management
Hormonal Regulation
Factors affecting Blood pressure
Physiological Factors:
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension and Regulation of Blood Pressure
